VaccineDanmark.dk ApS: Financial statements 2022
CVR: 42460699
Source: annual report 2022, Danish Business Authority
10/06/2021 – 30/06/2022
VaccineDanmark.dk ApS (CVR 42460699) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 11,472,642 and a net result of DKK 5,990,891. Equity in the 2022 report amounted to DKK 6,030,891. The solvency ratio was 71.6%. The company had 29 employees in the financial year.
- Gross Profit
- DKK 11,472,642
- Profit/Loss
- DKK 5,990,891
- Equity
- DKK 6,030,891
- Total Assets
- DKK 8,421,075
- Employees
- 29
Official annual report
Keep an eye on VaccineDanmark.dk ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout VaccineDanmark.dk ApS
VaccineDanmark.dk ApS is a Danish company of the type Anpartsselskab based in Herning, founded in 2021. The company is registered under the industry Speciallægers aktiviteter. The management consists of Damir Drljevic. The company is owned by DRDAM ApS. The company has 9 employees (2022). In 2025, the company reported a gross profit of DKK -21,698 and a net result of DKK -26,385 compared with DKK -185,176 the year before. Equity in the 2025 report amounted to DKK -152,771.